PubMed Health⌕ Search

Biomedical subjects

W Stauffacher

Publications and source records attributed to W Stauffacher.

At least 37 records · Page 2Linked to original sources

[The effect of salmon calcitonin on pancreatic enzymes and hormones before and after retrograde cholangiopancreatography].

The effect of salmon calcitonin (SMC) on pancreatic enzymes and hormones was investigated following retrograde choledocho-pancreatography (ERCP). 40 patients were randomly divided in two groups and 2.5 micrograms/h SMC or sodium chloride was infused intravenously for 28 hours. Infusion was started 4 hours before endoscopic procedure and amylase, lipase, glucose, insulin, glucagon and gastrin plasma concentrations were measured before and 2, 12 and 24 hours after the end of the ERCP. According to the radiological findings of pancreatography two additional groups were formed: group 1 with visualization of the main duct and its branches and group 2 with additional visualization of the pancreatic parenchyma. No change in glucose, insulin, glucagon and gastrin was found in any of the groups analyzed. Amylase and lipase showed a significant increase after 2 hours and 24 hours later, values were reached which were not significantly different to baseline levels. The time course of the plasma concentrations was identical in the patients treated by SMC or sodium chloride and showed no significant difference at the various time intervals. Therefore, inhibition of the known increase in pancreatic enzymes following ERCP was not found with SMC treatment.

Amylases↗

Validation of a tracer technique to determine nonsteady-state ketone body turnover rates in man.

The features of a single-compartment model of total ketone bodies were evaluated using primed constant infusions of [3-14C]acetoacetate (AcAc) and of D-[3-14C]beta-hydroxybutyrate (beta OHB) in 12 postabsorptive subjects. The volume of distribution (VD) of AcAc was 0.18 +/- 0.01 liter/kg (n = 9), and that of beta OHB was similar, 0.18 +/- 0.02 liter/kg (n = 3). The production rate of total ketone bodies was calculated using the combined specific activity of AcAc and of beta OHB. The mean basal total ketone body production rates were similar using either [14C]AcAc (6.5 mumol . kg-1 . min-1) or [14C]beta OHB (6.8 mumol . kg-1 . min-1). To determine the pool fraction that was rapidly mixed during nonsteady state of ketone body inflow, unlabeled AcAc was infused with stepwise increasing and decreasing rates between 5 and 25 mumol . kg-1 . m-1 to mimic nonsteady-state ketone body production rates. The "functional" pool fraction P was determined as the pool fraction that provided the best match between tracer-determined rates of ketone production and rates of AcAc infusion. P of total ketone bodies was almost equal to 1 using either [14C]AcAc (1.05 +/- 0.16) or [14C]beta OHB (1.00 +/- 0.06), suggesting rapid mixing of ketone bodies throughout the entire pool. The described pool model may be used to determine total ketone body kinetics during acute perturbations of the steady state.

Acetoacetates↗

[Loss of insulin during the infusion of insulin in glucose and nutrient solutions].

Controversial results of previous investigations prompted us to reassess the adsorptive loss of insulin to infusion bottles and tubings. An experimental array was chosen which was in strict accordance with the infusion technique used for the high-caloric parenteral nutrition of severely ill patients. The insulin concentrations were determined by a radioimmunoassay method. As in pure glucose solutions of various concentrations a loss of insulin amounting to about 30% was determined in high-caloric solutions containing aminoacids. The protective effect of human serum albumin, gelatine (Physiogel), and Rheomakrodex, all three of which diminish the insulin loss by about 50%, could be confirmed. The varying results obtained by different investigators may be attributable mainly to technical factors such as different surface properties of the infusion material, differences of the experimental array and analytical methods. Accordingly, variable losses of insulin may also occur in clinical practice. For daily routine an exact knowledge of these losses is irrelevant, since the insulin dosage is adjusted to the blood sugar level. However, if the insulin requirement is used as an index of the metabolic condition of the patient, precise determination of the actual loss is mandatory.

Absorption↗

[Mode of action and indication for appetite depressants in the treatment of obesity].

After a brief introductory discussion of methods generally used in the treatment of overweight (dieting; fasting; behavioral therapy; physical activity), the pharmacology of anorexigenic drugs and the considerations governing their clinical use and indications are discussed. All currently available anorexigens exert their action through nor-adrenergic stimulation at receptor sites located in the hypothalamus (amphetamine and ephedrine derivatives) or in the limbic system (Mazindol). In view of the CNS-stimulatory effect of these agents, drug addiction must be considered a potential hazard of their prolonged use. Since any drug treatment of obesity interferes with the patient's motivation to subject himself to the prolonged and possibly life-long changes in his eating habits and exertional behavior which are mandatory for the achievement of long-term therapeutic success, the use of drugs is rarely indicated in the treatment of obesity and should remain the exception. In view of their additional potential to induce drug addiction, this is particularly true of appetite suppressants.

Amphetamine↗

An apparent abnormaltiy of the B-cell microtubular system in spiny mice (Acomys cahirinus).

The pancreatic B-cell contains microtubules, which are thought to participate in the process of insulin release. In order to disclose a possible abnormaltiy of this B-cell microtubular system in animals with islet dysfunction, isolated islets from normal rats and mice, as well as from diabetic mutant mice (DBM mice) and from spiny mice (Acomys cahirinus) were incubated in the presence of vincristine, which causes the precipitation of the microtubular protein into paracrystalline deposits. Ultrastructural examination of the islets indicated that the volume-density of vincristine-induced deposits was markedly reduced in B-cells of spiny mice, when compared to that found in normal rats and mice and DBM mice. Exposure of the islets from spiny mice to a high glucose concentration, concomittantly to vincristine, caused a further reduction in vincristine-induced crystals content of the B-cell. It is speculated that an impairment of the B-cell microtubular system may account for the deficiency of insulin release found in spiny mice.

Animals↗